# dabigatran etexilate

NDC: 60505-4348
Generic name: dabigatran etexilate
Labeler / Manufacturer: Apotex Corp.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20240213

FDA application: ANDA208070

## Active ingredients

- DABIGATRAN ETEXILATE MESYLATE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60505-4348"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60505-4348
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd47a015-ff90-d7a7-8dcb-4e6e31a68071